These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 22617239)

  • 21. Fluorinated carbohydrates for
    Campbell E; Jordan C; Gilmour R
    Chem Soc Rev; 2023 Jun; 52(11):3599-3626. PubMed ID: 37171037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET Imaging of Metabolism, Perfusion, and Hypoxia: FDG and Beyond.
    Pantel AR; Bae SW; Li EJ; O'Brien SR; Manning HC
    Cancer J; 2024 May-Jun 01; 30(3):159-169. PubMed ID: 38753750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present role and future prospects of positron emission tomography in clinical oncology.
    Oriuchi N; Higuchi T; Ishikita T; Miyakubo M; Hanaoka H; Iida Y; Endo K
    Cancer Sci; 2006 Dec; 97(12):1291-7. PubMed ID: 17052261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography (PET) imaging with (18)F-based radiotracers.
    Alauddin MM
    Am J Nucl Med Mol Imaging; 2012; 2(1):55-76. PubMed ID: 23133802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.
    Davidson CQ; Phenix CP; Tai TC; Khaper N; Lees SJ
    Am J Nucl Med Mol Imaging; 2018; 8(3):200-227. PubMed ID: 30042871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.
    Werner JM; Lohmann P; Fink GR; Langen KJ; Galldiks N
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32213992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study.
    Ghafouri M; Duque L; Rodriguez LP; Philbrick KL; Savica R; Pazdernik VK; Port JD; Rummans TA; Singh B
    Schizophr Res; 2024 May; 267():138-140. PubMed ID: 38537394
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular imaging of urogenital diseases.
    Cho SY; Szabo Z
    Semin Nucl Med; 2014 Mar; 44(2):93-109. PubMed ID: 24484747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma.
    Kim D; Lee SH; Hwang HS; Kim SJ; Yun M
    Nucl Med Mol Imaging; 2024 Jun; 58(4):237-245. PubMed ID: 38932755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon.
    Toyama Y; Werner RA; Ruiz-Bedoya CA; Ordonez AA; Takase K; Lapa C; Jain SK; Pomper MG; Rowe SP; Higuchi T
    Theranostics; 2021; 11(12):6105-6119. PubMed ID: 33897902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular PET/MR imaging: Quo Vadis?
    Schindler TH
    J Nucl Cardiol; 2017 Jun; 24(3):1007-1018. PubMed ID: 27659454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrinology application of molecular imaging: current role of PET/CT.
    Calderoni L; Giovanella L; Fanti S
    J Endocrinol Invest; 2024 Jun; ():. PubMed ID: 38837101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging tumor metabolism using positron emission tomography.
    Lewis DY; Soloviev D; Brindle KM
    Cancer J; 2015; 21(2):129-36. PubMed ID: 25815854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of molecular imaging to advance translational research in chronic inflammation.
    Zhou W; Dey A; Manyak G; Teklu M; Patel N; Teague H; Mehta NN
    J Nucl Cardiol; 2021 Oct; 28(5):2033-2045. PubMed ID: 33244675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET/CT Imaging of Infectious Diseases: Overview of Novel Radiopharmaceuticals.
    Calabria FF; Guadagnino G; Cimini A; Leporace M
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring Metabolism In Vivo Using Endogenous
    Neumann K; Flavell R; Wilson DM
    Semin Nucl Med; 2017 Sep; 47(5):461-473. PubMed ID: 28826521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.
    Lopci E; Grassi I; Chiti A; Nanni C; Cicoria G; Toschi L; Fonti C; Lodi F; Mattioli S; Fanti S
    Am J Nucl Med Mol Imaging; 2014; 4(4):365-84. PubMed ID: 24982822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear medicine and molecular imaging advances in the 21st century.
    Vaz SC; Oliveira F; Herrmann K; Veit-Haibach P
    Br J Radiol; 2020 Jun; 93(1110):20200095. PubMed ID: 32401541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Lensless Radiomicroscope for Cellular-Resolution Radionuclide Imaging.
    Klein JS; Kim TJ; Pratx G
    J Nucl Med; 2023 Mar; 64(3):479-484. PubMed ID: 36109183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection Imaging: Focus on New Tracers?
    Roll W; Faust A; Hermann S; Schäfers M
    J Nucl Med; 2023 Nov; 64(Suppl 2):59S-67S. PubMed ID: 37918846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.